|
US6495130B1
|
|
Target cell-specific adenoviral vectors containing E3 and methods of use thereof
|
|
AU3292499A
|
|
Prostate cancer drug screening
|
|
EP0968298A2
|
|
Adenovirus vectors specific for cells expressing carcinoembryonic antigen and methods of use thereof
|
|
WO9839467A2
|
|
Adenovirus vectors specific for cells expressing carcinoembryonic antigen and methods of use thereof
|
|
US6197293B1
|
|
Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof
|
|
US6254862B1
|
|
Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof
|
|
US6051417A
|
|
Prostate cancer drug screening using hKLK2 enhancer
|
|
US6057299A
|
|
Tissue-specific enhancer active in prostate
|
|
US5698443A
|
|
Tissue specific viral vectors
|
|
MX9602744A
|
|
Tissue-specific enhancer active in prostate.
|
